In recent years, the rapid advancement of biotechnology has significantly increased the proportion of bioharmaceutical products in the global pharmaceutical market. Meanwhile, residual host cell DNA (rcDNA) has become a major concern due to its potential infectious or carcinogenic risks. To ensure the safety of biopharmaceuticals, most biological products require strict monitoring and proof of rcDNA clearance throughout the entire production process. Currently, commonly employed detection methods include real-time quantitative PCR (qPCR), droplet digital PCR (ddPCR), DNA probe hybridization, and fluorescent staining methods, among others. While these technologies each offer distinct advantages, they also face challenges in comprehensively detecting potential rcDNA. This review explores the potential sources of rcDNA in biopharmaceutical products and provides an in-depth evaluation of existing detection methods. It systematically analyzes and compares the strengths and limitations of various techniques, and discusses future directions for the development of rcDNA detection technologies. This work aims to offer valuable insights and references for improving the detection and control of rcDNA in biopharmaceutical production.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |